PEDIARIX

Biological GlaxoSmithKline, LLC.
Total Payments
$2.5M
Transactions
10,560
Doctors
6,018
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $6,234 350 318
2023 $22,092 1,233 1,026
2022 $30,721 1,729 1,425
2021 $29,288 1,808 1,443
2020 $95,199 1,287 1,035
2019 $286,490 1,617 1,273
2018 $2.0M 1,324 550
2017 $19,005 1,212 897

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.3M 792 93.3%
Food and Beverage $162,529 9,766 6.6%
Space rental or facility fees (teaching hospital only) $2,400 2 0.1%

Payments by Type

Research
$2.3M
792 transactions
General
$164,929
9,768 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
ROTA-090 GlaxoSmithKline, LLC. $2.3M 0
ROTA-081 GlaxoSmithKline, LLC. $540.00 0

Top Doctors Receiving Payments for PEDIARIX — Page 241

Doctor Specialty Location Total Records
, MD Internal Medicine Mesquite, TX $3.00 1
, MD Family Medicine Mesquite, TX $3.00 1
, M.D Pediatrics Olean, NY $2.65 1
, D.O Pediatrics Kennesaw, GA $2.50 1
, M.D Pediatrics Staten Island, NY $2.49 1
, MD Pediatrics El Paso, TX $2.49 1
, M.D Pediatrics Round Rock, TX $2.13 1
Alanna Sedor Pediatrics Miami, FL $1.65 1
, MD Pediatrics Mobile, AL $1.47 1
, MD Rheumatology Glendale, CA $1.25 1
, M.D Family Medicine Wichita, KS $1.10 1
, M.D Family Medicine Wichita, KS $1.09 1
, FNP-C Family New Albany, MS $0.93 1
, MD Family Medicine Indianapolis, IN $0.86 1
, DO Family Medicine Indianapolis, IN $0.86 1
, MD Pediatrics Mount Vernon, NY $0.83 1
, M.D Pediatrics Passaic, NJ $0.72 1
, PA Physician Assistant Passaic, NJ $0.72 1
, M.D Family Medicine Houston, TX $0.64 1

About PEDIARIX

PEDIARIX is a biological associated with $2.5M in payments to 6,018 healthcare providers, recorded across 10,560 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..

Payment data is available from 2017 to 2024. In 2024, $6,234 was paid across 350 transactions to 318 doctors.

The most common payment nature for PEDIARIX is "Unspecified" ($2.3M, 93.3% of total).

PEDIARIX is associated with 2 research studies, including "ROTA-090" ($2.3M).